drugset / Trial / NCT01915667
Oral Bioavailability of Two Solid Formulations of GLPG0634
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of the study is to evaluate the amount of compound present in the blood (relative bioavailability) after a single administration of GLPG0634 as a tablet versus a capsule in fasted conditions in male healthy subjects. Also, the effect of food on the bioavailability of the tablet formulation will be studied as well as the safety and tolerability of single oral doses of GLPG0634 given either as capsule or tablet.
Timeline
- Start
- 2013-07
- Primary completion
- 2013-09
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Filgotinib | Small molecule | 200 mg | Oral |
Indications
No indication recorded.